SURGERY PARTNERS INC
SGRYNASDAQTrading Snapshot
- Day Range
- $14.24 β $14.56
- 52-Week Range
- $11.41 β $23.44
- Volume
- $5.66B
- Avg Volume
- $5.83B
- Shares Outstanding
- 130.8M
- Next Earnings
- Oct 30, 2026
Fundamentals Snapshot
- Annual Revenue
- $3.31B
- Last Q Revenue
- $849M
- P/E Ratio
- -21.3
- P/S Ratio
- 0.6x
- EPS (TTM)
- $-0.69
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +0.8%
Why Investors Own SGRY
- βHigh-growth profile β revenue up +0.4% YoY with expanding US Equity exposure.
- βHealthy economics β 48% gross margin and 17% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SURGERY PARTNERS INC
SGRYAbout SURGERY PARTNERS INC
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilitiesβspecifically, 108 ambulatory surgical centers and 18 surgical hospitalsβsituated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock?
Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term

Surgery Partners: A 'Buy' After Idaho Falls Asset Divestment
I initiate coverage of Surgery Partners with a Buy, citing positives relating to the Idaho Falls divestiture. SGRY's asset sale reduces leverage, improves cash flow, and shifts payor mix away from Medicaid. That also sim

Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction
BRENTWOOD, Tenn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (βSurgery Partnersβ or the βCompanyβ), a leading short-stay surgical facility owner and operator, today announced it has completed

Surgery Partners Director Teresa DeLuca Buys 11,250 Shares
The purchase was valued at approximately $161,000. DeLuca's total position now consists of 68,093 shares.

6,241,503 Shares in Surgery Partners, Inc. $SGRY Purchased by BlackRock Inc.
BlackRock Inc. acquired a new position in shares of Surgery Partners, Inc. (NASDAQ: SGRY) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 6,24

Likely ETF & Stock Winners From July Jobs Report
Weak July jobs data raises hopes for Fed easing, putting health care and select retail ETFs and stocks in focus.